Vaxart, Inc.

VXRT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 20, 2026 FORM 4
3 Oct 20, 2026 FORM 3
8-K Oct 19, 2026 FORM 8-K
8-K Sep 14, 2026 FORM 8-K
8-K Aug 25, 2026 FORM 8-K
10-Q Aug 6, 2026 FORM 10-Q
8-K Aug 6, 2026 FORM 8-K
8-K Jul 28, 2026 FORM 8-K
4 Jul 20, 2026 FORM 4
4 Jul 17, 2026 FORM 4
4 Jul 17, 2026 FORM 4
4 Jul 17, 2026 FORM 4
4 Jul 17, 2026 FORM 4
8-K Jul 17, 2026 FORM 8-K
8-K Jul 7, 2026 FORM 8-K
DEFA14A Jul 6, 2026 DEFINITIVE ADDITIONAL MATERIALS
DEFA14A Jul 2, 2026 DEFINITIVE ADDITIONAL MATERIALS
DFAN14A Jul 2, 2026
8-K Jul 2, 2026 CURRENT REPORT
DEFA14A Jul 1, 2026 DEFINITIVE ADDITIONAL MATERIALS
DEFA14A Jun 26, 2026 DEFINITIVE ADDITIONAL MATERIALS
DEFA14A Jun 26, 2026 DEFINITIVE ADDITIONAL MATERIALS
8-K Jun 26, 2026 FORM 8-K
DEFA14A Jun 26, 2026 DEFINITIVE ADDITIONAL MATERIALS
DEFA14A Jun 26, 2026 DEFINITIVE ADDITIONAL MATERIALS
← Newer Page 1 of 65 · 1610 filings Older →